Independently scored across 5 dimensions · Updated weekly · No paid placements
Home›Programs›Found
Found logo

Found

The widest medication catalog in the chart — paired with the most hostile lock-in short of WeightWatchers
Visit Found ↗
6.2
Out of 10
Starts From
$99/mo
+ medication separate
Lock-In
6-month lock-in
Time to Rx
5 days
Asynchronous
Score
6.2 / 10
Rank #6 of 20

Verdict

Found has the broadest medication catalog of any program here, including off-label tirzepatide and orforglipron access through their Foundayo program. The 6-month non-refundable subscription is the catch.

Best for

  • Patients whose obesity medicine clinician has flagged a non-standard medication path (multiple drug classes, off-label combinations, or 503A-compounded options that other programs have exited).

Not for

  • Patients new to GLP-1s who want a simple month-to-month commitment. The 6-month lock with non-refundable fees is the most punitive structure short of WeightWatchers Clinic.

Pricing

CORE 6-month plan: $594 upfront ($99/mo). After commitment expires, rolls to $129/mo. Kickstart 3-month plan exists at a slightly lower intro. Medication billed separately. Compounded semaglutide ~$189/mo cash.

Cash-pay all-in starts at $99/moThis is the membership only — medication is billed separately.

Lock-in & cancellation

6-month lock-in

$594 upfront for 6 months. Subscription fees explicitly non-refundable per offer terms. No clean way to leave inside the commitment window.

Medication options

Both FDA-approved branded via partner pharmacies and 503A-compounded for cash-pay paths. Foundayo is Found's branded compounded orforglipron protocol — the only such offering in the chart.

FDA-approved branded

503A-compounded

Other medications

Regulatory notes
  • Operates Foundayo, a proprietary compounded orforglipron protocol with active FDA monitoring
  • Subject to ongoing Lilly compounded-tirzepatide enforcement risk

Onboarding experience

Time to first prescription: 5 days.
Consultation type: Asynchronous with a metabolic questionnaire.
Requirements: Weight, BMI, medical history, metabolic questionnaire.

Member feedback

On r/WeightLossAdvice and r/glp1, Found is praised for medication variety and criticized for the lock-in. The non-refundable structure is the dominant negative across forum mentions.

What works

  • Medication variety unmatched in the category
  • Clinician willingness to consider off-label combinations
  • Foundayo orforglipron protocol is genuinely unusual

What to watch

  • 6-month non-refundable lock
  • Medication swaps without warning during supply gaps
  • Billing continues during paused care

How we scored Found

Five dimensions, ten points each, weighted equally. Overall is the simple average.

6
Pricing
Transparency
3
Cancellation
Terms
8
Onboarding
Experience
9
Medication
Options
5
Member
Outcomes

Read the full methodology →

Frequently asked questions

Can I get out of the Found 6-month lock-in?
Not financially. The subscription fees are non-refundable per the offer terms you accept at signup. You can stop using the service, but you cannot recover the $594 upfront. The Kickstart 3-month plan is the lowest-commitment option Found offers if the 6-month lock concerns you.
What is Foundayo?
Foundayo is Found's branded program for compounded orforglipron, a GLP-1 still in pre-launch FDA review for branded approval. Until orforglipron is approved as a branded product, Found prepares it through 503A pharmacies. This is the only major program offering it. The regulatory status is fluid.
Why is Found ranked lower than Mochi if it has more medications?
Found scores higher than Mochi on medication options (9 vs 6), but the 6-month non-refundable lock-in pulls cancellation terms to a 3 out of 10. Our methodology weights cancellation equally with medication, so the lock penalty drops Found's overall to 6.2.

Alternatives to Found

If Found isn't the right fit, here are three programs we'd consider as next options:

Mochi Health
Compounded GLP-1 specialist with the cleanest pricing in the chart
Noom Med
Behavioral psychology meets medication, with an unusual microdose tier
Calibrate
Coaching-first program, recently restructured, with a notable upfront fee

See the full chart →

J
John, Editor Independent comparison site operator. Australian-based, US-focused. About this site · Contact
Why you can trust GLP Chart Same scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each provider's public-facing page weekly.
Independent comparison site. Not a medical provider, telehealth platform, or pharmacy. Information is educational, not medical advice. Always consult a licensed clinician. We may earn a commission on partner links at no cost to you.